Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline Combined With Multi-Strain Probiotics in Adolescent Patients With Depression
NCT07645157Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing Sertraline combined with compound probiotics group with Sertraline combined with placebo group (2 arms). Primary endpoint: Children's Depression Rating Scale - Revised at week 8. Started Oct 2026; status: recruiting.
02
Drugs
probiotic complex
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07645157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07645157.